These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. High prevalence of viral infection in adults with homozygous and heterozygous alpha 1-antitrypsin deficiency and chronic liver disease. Propst T, Propst A, Dietze O, Judmaier G, Braunsteiner H, Vogel W. Ann Intern Med; 1992 Oct 15; 117(8):641-5. PubMed ID: 1530195 [Abstract] [Full Text] [Related]
10. Prevalence of antibodies to hepatitis C virus in patients with hepatocellular carcinoma in Austria. Baur M, Hay U, Novacek G, Dittrich C, Ferenci P. Arch Virol Suppl; 1992 Oct 15; 4():76-80. PubMed ID: 1280509 [Abstract] [Full Text] [Related]
11. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans. El-Serag HB, Richardson PA, Everhart JE. Am J Gastroenterol; 2001 Aug 15; 96(8):2462-7. PubMed ID: 11513191 [Abstract] [Full Text] [Related]
15. Prevalence of hepatocellular carcinoma in patients with alcoholic cirrhosis and prior exposure to hepatitis C. Yamauchi M, Nakahara M, Maezawa Y, Satoh S, Nishikawa F, Ohata M, Mizuhara Y, Hirakawa J, Nakajima H, Fujisawa K. Am J Gastroenterol; 1993 Jan 15; 88(1):39-43. PubMed ID: 7678368 [Abstract] [Full Text] [Related]
19. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India. Kumar M, Kumar R, Hissar SS, Saraswat MK, Sharma BC, Sakhuja P, Sarin SK. J Gastroenterol Hepatol; 2007 Jul 15; 22(7):1104-11. PubMed ID: 17559381 [Abstract] [Full Text] [Related]